Securities code: Jinghua Pharmaceutical Group Co.Ltd(002349) securities abbreviation: Jinghua Pharmaceutical Group Co.Ltd(002349) Announcement No.: 2022009 Jinghua Pharmaceutical Group Co.Ltd(002349)
Announcement of shareholders on reducing their shares of the company to 1%
The shareholders Nantong variety Investment Co., Ltd. and Mr. min Shengda guarantee that the contents of the announcement are true, accurate and complete, and are responsible for the false records, misleading statements or major omissions in the announcement.
Jinghua Pharmaceutical Group Co.Ltd(002349) (hereinafter referred to as “the company”) recently received a notification letter from Nantong variety Investment Co., Ltd. and Mr. min Shengda, the shareholders holding more than 5% of the company’s shares, and learned that from January 18, 2022 to January 20, 2022, Nantong variety investment and Mr. min Shengda reduced 8247243 shares of the company through the centralized bidding transaction of the stock exchange, and the reduction proportion was 0.99% of the total share capital of the company at the time of disclosure of the reduction plan.
On March 16, 2022, the company disclosed the announcement of Jinghua Pharmaceutical Group Co.Ltd(002349) on the completion of share repurchase cancellation and share change. The company’s total share capital changed due to the cancellation of shares in the special securities account for repurchase. After cancellation, the total number of shares of the company was changed from 835724374 shares to 814180908 shares. The reduction of shareholders’ holdings is now disclosed as follows:
1. Basic information
Information disclosure obligor: Nantong variety Investment Co., Ltd., Mr. min Shengda
Address: Nantong City, Jiangsu Province
Changes in equity from January 18, 2022 to January 20, 2022
Stock abbreviation Jinghua Pharmaceutical Group Co.Ltd(002349) stock code Jinghua Pharmaceutical Group Co.Ltd(002349)
Change type increase □ decrease \uf0fe concerted action person yes \uf0fe no □
(multiple choices are allowed)
Whether it is the largest shareholder or actual controller yes □ no \uf0fe
2. Changes in equity this time
Type of shares number of shares reduced (10000 shares) reduction proportion (%)
A shares 824.72 1.01
Total 824.72 1.01
The way of this equity change (multiple choices) is through the centralized trading of the stock exchange \uf0fe agreement transfer □ through the block trading of the stock exchange □ indirect transfer □ administrative transfer or change of state-owned shares □ execution of court ruling □
Securities code: Jinghua Pharmaceutical Group Co.Ltd(002349) securities abbreviation: Jinghua Pharmaceutical Group Co.Ltd(002349) Announcement No.: 2022009
Acquisition of new shares issued by listed companies □ succession □
Gift □ transfer of voting rights □
Others □ (please specify)
Self owned funds □ bank loans □
The capital source of this share increase is loans from other financial institutions □ shareholder investment □
(multiple choices are allowed) others □ (please specify)
Not involving the source of funds \uf0fe
3. Shares of listed companies owned by investors and persons acting in concert before and after the change
Shares held before this change shares held after this change
Nature of shares proportion of shares (10000 shares) to the latest total share capital proportion of shares (10000 shares) to the latest total share capital example (%) (%)
Total shares held 817067 10.035734594 9.022
Including: shares with unlimited sales conditions 817067 10.035734594 9.022
Shares with limited sales conditions 0
4. Implementation of commitments, plans, etc
Yes \uf0fe no □
The company disclosed the pre disclosure announcement on the share reduction plan of shareholders holding more than 5% shares on cninfo.com on December 23, 2021. Whether the change is to fulfill the total number of shares of the company not exceeding 16714486, that is, not exceeding 2% of the total number of shares of the company, as of the date of disclosure of the commitments, intentions and plans announced in this announcement, Variety investment and Mr. min Shengda have reduced 8247243 shares through centralized bidding, accounting for 1.01% of the company’s total share capital. The reduction plan has not been fully implemented.
The information disclosure obligor will continue to strictly comply with the regulatory requirements related to the reduction of shareholders’ holdings.
Is there any violation in this change
Securities law, purchase of listed companies yes □ no \uf0fe
Management measures and other laws, administrative regulations, departmental rules, normative documents and the business rules of the exchange 5 Shares with restricted voting rights
According to Article 63 of the securities law, yes □ no \uf0fe
Whether there are shares that cannot exercise voting rights
Securities code: Jinghua Pharmaceutical Group Co.Ltd(002349) securities abbreviation: Jinghua Pharmaceutical Group Co.Ltd(002349) Announcement No.: 2022009
6. Further explanation on the transfer of voting rights (not applicable) further explanation on the increase of shares held by more than 7.30% shareholders (not applicable) 8 Documents for future reference: notification letter of Nantong variety Investment Co., Ltd. and Mr. min Shengda on the progress of reducing Jinghua Pharmaceutical Group Co.Ltd(002349) shares and reaching 1% reduction
It is hereby announced.
Jinghua Pharmaceutical Group Co.Ltd(002349) board of directors March 21, 2022
